Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Related Posts
Stirrat TS, Tian T, Solanky P, Apte S, Shahrin S, Flatley M, Thiru S, Kakde S, Kanth P. Training Stage, Program Pedigree, Degree Pathway, and[...]
Tang AB, Greene SJ, Fonarow GC. Response by Fonarow et al to Letter Regarding Article, "Improving Heart Failure Quality of are Over the First Twenty[...]
Gandhi SA, Liu GY, Fazio JC, Amubieya O, Barnes H, Cavalin C, Cohen RA, Fireman E, Garcia SR, Harrison RJ, Houlroyd JL, Hua JT, Jones[...]